Existing UCSF customers: Learn about transitioning from UCSF to Delve here.

Know more unknowns

Diagnosing an infection often means guessing before testing. Now there’s a better way. Quickly identify all types of pathogens using a single, comprehensive, metagenomic test. Meet Delve Detect.

Delve_YellowBackground-min-1024x886
DelveDetect

Get answers faster

Delve Detect delivers more comprehensive detection of pathogens than traditional microbiology tools. Accurately identify bacteria, viruses, fungi, and parasites from a single sample in a single test.

  • Broad, agnostic, hypothesis-free detection
  • Results available 2 days after sample arrives at the lab
  • Sampling of all genomic content – DNA and RNA – in cerebrospinal fluid (CSF)
  • Delve Decide – our proprietary curated pathogen database, bioinformatic pipeline, and clinical interpretation software analyzes millions of sequences against a curated database of over 68,000 unique species

Leading laboratories and hospitals have trusted the technology behind Delve Detect for years. Find out why.

Learn More

mNGS ends the serial, test-after-test cycle

 

 

Featured News

  • BUSINESS WIRE

    Delve Bio and UCSF Publish Research Demonstrating Clinical Utility of Metagenomic Next-Generation Sequencing (mNGS) for Diagnosing Serious Neurological Infections

    Paper published in Nature Medicine includes real world experience diagnosing difficult-to-detect pathogens in challenging central nervous system infections.

    Read More

    BUSINESS WIRE

  • NATURE MEDICINE

    Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infections

    Metagenomic next-generation sequencing (mNGS) of cerebrospinal fluid (CSF) is an agnostic method for broad-based diagnosis of central nervous system (CNS) infections.

    Read More

    NATURE MEDICINE

  • WEBINAR

    Delve’s Co-Founder Charles Chiu presents at ASM Clinical Microbiology Virtual Journal Club

    Delve co-founder, Dr. Charlies Chiu, joined ASM Clinical Microbiology Virtual Journal Club to discuss performance and stewardship of clinical metagenomics for central nervous systems infections.

    Read More

    WEBINAR

  • BUSINESS WIRE

    Delve Bio Announces Partnership with Broad Clinical Labs for Metagenomic Next Generation Sequencing (mNGS)

    Delve Bio and Broad Clinical Labs announce a partnership to rapidly scale up access to metagenomic testing for patients with neurological infections.

    Read More

    BUSINESS WIRE

  • ENCEPHALITIS INTERNATIONAL

    Delve’s Co-Founder Michael Wilson Featured on Encephalitis International podcast

    Delve co-founder, Dr. Michael Wilson, joined Encephalitis International to discuss the difficulties in diagnosing encephalitis and how new technologies can help patients get answers faster.

    Read More

    ENCEPHALITIS INTERNATIONAL

  • BUSINESS WIRE

    Delve Bio Announces Clinical Data on the Use of Metagenomic Next-Generation Sequencing (mNGS) to Identify Pathogens Causing Central Nervous System Infections

    In a study of more than 4,800 patients over seven years, mNGS testing detected pathogens in nearly 15% of samples, encompassing more than 440 unique pathogen species

    Read More

    BUSINESS WIRE

Ready to get answers for your patients sooner?

Choose Delve Detect.

Talk To Us

Backed by Clinical Data

Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis.

THE NEW ENGLAND JOURNAL OF MEDICINE 2019

READ MORE
Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing.

THE NEW ENGLAND JOURNAL OF MEDICINE 2014

READ MORE
Rapid Pathogen Detection by Metagenomic Next-Generation Sequencing of Infected Body Fluids.

NAT MED 2021

READ MORE
Clinical metagenomics.

NATURE REVIEWS: GENETICS 2019

READ MORE
Metagenomics for neurological infections — expanding our imagination.

NATURE REVIEWS: NEUROLOGY 2020

READ MORE
A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples.

GENOME RESEARCH 2014

READ MORE
Enhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and Encephalitis.

AMERICAN SOCIETY FOR MICROBIOLOGY 2021

READ MORE
Metagenomic Next-Generation Sequencing for Diagnosis of Pediatric Meningitis and Encephalitis: A Review

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY 2021

READ MORE
ucsf-logo-min

As exclusive licensee of University of California San Francisco’s (UCSF) metagenomic sequencing (mNGS) technology, Delve Bio is now the exclusive provider of the UCSF mNGS test.

Our streamlined order process takes you from sample to answer in 2 days

1. Receive Delve sample kit, free-of-charge

2. Complete requisition form and transfer CSF

3. Fax requisition form

4. Ship sample at room temperature using kit box (prepaid)

5. Receive results 2 days after sample is received

Make unknowns known – faster

Avoid getting lost in the test-after-test cycle. Get started with Delve Detect today.

Learn more